{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:48:06Z","timestamp":1791852486900,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T00:00:00Z","timestamp":1438646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T00:00:00Z","timestamp":1438646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms8939","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T05:59:07Z","timestamp":1438667947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":213,"title":["A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models"],"prefix":"10.1038","volume":"6","author":[{"given":"Jayanta","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Bellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Weitzhandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Spasojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Tsan Ashley","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Chilkoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,4]]},"reference":[{"key":"BFncomms8939_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/bmj.4.5730.259","volume":"4","author":"RB Scott","year":"1970","unstructured":"Scott, R. B. Cancer chemotherapy-the first twenty-five years. Br. Med. J. 4, 259\u2013265 (1970).","journal-title":"Br. Med. J."},{"key":"BFncomms8939_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc2559","volume":"9","author":"J Zhang","year":"2009","unstructured":"Zhang, J., Yang, P. L. & Gray, N. S. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer 9, 28\u201339 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms8939_CR3","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/nbt1171","volume":"23","author":"CC Lee","year":"2005","unstructured":"Lee, C. C., MacKay, J. A., Frechet, J. M. J. & Szoka, F. C. Designing dendrimers for biological applications. Nat. Biotechnol. 23, 1517\u20131526 (2005).","journal-title":"Nat. Biotechnol."},{"key":"BFncomms8939_CR4","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387\u20136392 (1986).","journal-title":"Cancer Res."},{"key":"BFncomms8939_CR5","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/anie.201200899","volume":"52","author":"JR McDaniel","year":"2013","unstructured":"McDaniel, J. R. et al. Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation. Angew. Chem. Int. Ed. 52, 1683\u20131687 (2013).","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFncomms8939_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nmat2569","volume":"8","author":"JA MacKay","year":"2009","unstructured":"MacKay, J. A. et al. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat. Mater. 8, 993\u2013999 (2009).","journal-title":"Nat. Mater."},{"key":"BFncomms8939_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/j.1552-4604.1990.tb01873.x","volume":"30","author":"WJ Slichenmyer","year":"1990","unstructured":"Slichenmyer, W. J. & Von Hoff, D. D. New natural products in cancer chemotherapy. J. Clin. Pharmacol. 30, 770\u2013788 (1990).","journal-title":"J. Clin. Pharmacol."},{"key":"BFncomms8939_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1860-5397-2-13","volume":"2","author":"K Bombuwala","year":"2006","unstructured":"Bombuwala, K. et al. Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel. Beilstein J. Org. Chem. 2, 13 (2006).","journal-title":"Beilstein J. Org. Chem."},{"key":"BFncomms8939_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1586\/14737140.2.2.143","volume":"2","author":"T Tejada-Berges","year":"2002","unstructured":"Tejada-Berges, T., Granai, C. O., Gordinier, M. & Gajewski, W. Caelyx\/Doxil for the treatment of metastatic ovarian and breast cancer. Expert Rev. Anticancer Ther. 2, 143\u2013150 (2002).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"BFncomms8939_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","volume":"7","author":"WJ Gradishar","year":"2006","unstructured":"Gradishar, W. J. Albumin-bound paclitaxel: a next-generation taxane. Expert Opin. Pharmacother. 7, 1041\u20131053 (2006).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFncomms8939_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0968-0004(00)01670-4","volume":"25","author":"AS Tatham","year":"2000","unstructured":"Tatham, A. S. & Shewry, P. R. Elastomeric proteins: biological roles, structures and mechanisms. Trends Biochem. Sci. 25, 567\u2013571 (2000).","journal-title":"Trends Biochem. Sci."},{"key":"BFncomms8939_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/15100","volume":"17","author":"DE Meyer","year":"1999","unstructured":"Meyer, D. E. & Chilkoti, A. Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat. Biotechnol. 17, 1112\u20131115 (1999).","journal-title":"Nat. Biotechnol."},{"key":"BFncomms8939_CR13","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1021\/ja981803d","volume":"120","author":"J Massey","year":"1998","unstructured":"Massey, J., Power, K. N., Manners, I. & Winnik, M. A. Self-assembly of a novel organometallic\u2212inorganic block copolymer in solution and the solid state: nonintrusive observation of novel wormlike poly(ferrocenyldimethylsilane)-b-poly(dimethylsiloxane) micelles. J. Am. Chem. Soc. 120, 9533\u20139540 (1998).","journal-title":"J. Am. Chem. Soc."},{"key":"BFncomms8939_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai, N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 14, 282\u2013295 (2012).","journal-title":"AAPS J."},{"key":"BFncomms8939_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrc1713","volume":"5","author":"RA Cardone","year":"2005","unstructured":"Cardone, R. A., Casavola, V. & Reshkin, S. The role of disturbed pH dynamics and the a+\/H+ exchanger in metastasis. Nat. Rev. Cancer 5, 786\u2013795 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms8939_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nrm883","volume":"3","author":"A Sorkin","year":"2002","unstructured":"Sorkin, A. & von Zastrow, M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 3, 600\u2013614 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFncomms8939_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctrv.2009.12.002","volume":"36","author":"A Bosch","year":"2010","unstructured":"Bosch, A., Eroles, P., Zaragoza, R., Vi\u00f1a, J. R. & Lluch, A. Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treat. Rev. 36, 206\u2013215 (2010).","journal-title":"Cancer Treat. Rev."},{"key":"BFncomms8939_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1634\/theoncologist.2011-S1-01","volume":"16","author":"CA Hudis","year":"2011","unstructured":"Hudis, C. A. & Gianni, L. Triple-negative breast cancer: an unmet medical need. Oncologist 16, 1\u201311 (2011).","journal-title":"Oncologist"},{"key":"BFncomms8939_CR19","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","volume":"88","author":"TH Wang","year":"2000","unstructured":"Wang, T. H., Wang, H. S. & Soong, Y. K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88, 2619\u20132628 (2000).","journal-title":"Cancer"},{"key":"BFncomms8939_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0378-5173(01)00986-3","volume":"235","author":"AK Singla","year":"2002","unstructured":"Singla, A. K., Garg, A. & Aggarwal, D. Paclitaxel and its formulation. Int. J. Pharm. 235, 179\u2013192 (2002).","journal-title":"Int. J. Pharm."},{"key":"BFncomms8939_CR21","first-page":"107","volume":"15","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky, E. K., Chaudhry, V., Cornblath, D. R. & Donehower, R. C. Neurotoxicity of taxol. J. Natl. Cancer Inst. Monogr. 15, 107\u2013115 (1993).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"BFncomms8939_CR22","unstructured":"US Food & Drug Administration, Center for Drug Evaluation and Research. New Drug Application Pharmacology Review 21-660. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/21660_ABRAXANE_pharmr.PDF (2004)."},{"key":"BFncomms8939_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s002800000168","volume":"46","author":"C Li","year":"2000","unstructured":"Li, C. et al. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Cancer Chemother. Pharmacol. 46, 416\u2013422 (2000).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFncomms8939_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1158\/0008-5472.CAN-11-2076","volume":"72","author":"X Tang","year":"2012","unstructured":"Tang, X. et al. Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer Res. 72, 491\u2013502 (2012).","journal-title":"Cancer Res."},{"key":"BFncomms8939_CR25","doi-asserted-by":"publisher","first-page":"e1001093","DOI":"10.1371\/journal.pgen.1001093","volume":"6","author":"JL-Y Chen","year":"2010","unstructured":"Chen, J. L-Y. et al. Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet. 6, e1001093 (2010).","journal-title":"PLoS Genet."},{"key":"BFncomms8939_CR26","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms8939_CR27","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(95)90963-X","volume":"345","author":"WB Shelley","year":"1995","unstructured":"Shelley, W. B., Talanin, N. & Shelley, E. D. Polysorbate 80 hypersensitivity. Lancet 345, 1312\u20131313 (1995).","journal-title":"Lancet"},{"key":"BFncomms8939_CR28","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","volume":"37","author":"H Gelderblom","year":"2001","unstructured":"Gelderblom, H., Verweij, J., Nooter, K. & Sparreboom, A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37, 1590\u20131598 (2001).","journal-title":"Eur. J. Cancer"},{"key":"BFncomms8939_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0304-3835(96)04380-7","volume":"107","author":"A Sharma","year":"1996","unstructured":"Sharma, A., Sharma, U. S. & Straubinger, R. M. Paclitaxel-liposomes for intracavity therapy of intraperitoneal P388 leukemia. Cancer Lett. 107, 265\u2013272 (1996).","journal-title":"Cancer Lett."},{"key":"BFncomms8939_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/annonc\/mdp315","volume":"21","author":"WT Lim","year":"2010","unstructured":"Lim, W. T. et al. Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. Ann. Oncol. 21, 382\u2013388 (2010).","journal-title":"Ann. Oncol."},{"key":"BFncomms8939_CR31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.bjc.6602479","volume":"92","author":"T Hamaguchi","year":"2005","unstructured":"Hamaguchi, T. et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br. J. Cancer 92, 1240\u20131246 (2005).","journal-title":"Br. J. Cancer"},{"key":"BFncomms8939_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2009.11.012","volume":"143","author":"G Gaucher","year":"2010","unstructured":"Gaucher, G., Marchessault, R. H. & Leroux, J. C. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Control. Release 143, 2\u201312 (2010).","journal-title":"J. Control. Release"},{"key":"BFncomms8939_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejpb.2008.08.003","volume":"71","author":"K Letchford","year":"2009","unstructured":"Letchford, K., Liggins, R., Wasan, K. M. & Burt, H. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles. Eur. J. Pharm. Biopharm. 71, 196\u2013206 (2009).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"BFncomms8939_CR34","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","volume":"23","author":"WJ Gradishar","year":"2005","unstructured":"Gradishar, W. J. et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castoroil-based paclitaxel in women with breast cancer. J. Clin. Oncol. 23, 7794\u20137803 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFncomms8939_CR35","doi-asserted-by":"publisher","first-page":"7768","DOI":"10.1200\/JCO.2005.08.002","volume":"23","author":"M Harries","year":"2005","unstructured":"Harries, M., Ellis, P. & Harper, P. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J. Clin. Oncol. 23, 7768\u20137771 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFncomms8939_CR36","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1200\/JCO.2004.00.6148","volume":"23","author":"DW Nyman","year":"2005","unstructured":"Nyman, D. W. et al. Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced non hematologic malignancies. J. Clin. Oncol. 23, 7785\u20137793 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFncomms8939_CR37","first-page":"99","volume":"4","author":"E Miele","year":"2009","unstructured":"Miele, E., Spinelli, G. P., Miele, E., Tomao, F. & Tomao, S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int. J. Nanomedicine 4, 99\u2013105 (2009).","journal-title":"Int. J. Nanomedicine"},{"key":"BFncomms8939_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jconrel.2012.07.043","volume":"162","author":"MJ Ernsting","year":"2012","unstructured":"Ernsting, M. J. et al. A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases. J. Control Release 162, 575\u2013581 (2012).","journal-title":"J. Control Release"},{"key":"BFncomms8939_CR39","doi-asserted-by":"publisher","first-page":"7834","DOI":"10.1158\/1078-0432.CCR-05-0803","volume":"11","author":"AV Boddy","year":"2005","unstructured":"Boddy, A. V. et al. A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules. Clin. Cancer Res. 11, 7834\u20137840 (2005).","journal-title":"Clin. Cancer Res."},{"key":"BFncomms8939_CR40","first-page":"2404","volume":"58","author":"C Li","year":"1998","unstructured":"Li, C. et al. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res. 58, 2404\u20132409 (1998).","journal-title":"Cancer Res."},{"key":"BFncomms8939_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1248\/bpb.35.280","volume":"35","author":"TL Zhao","year":"2012","unstructured":"Zhao, T. L. et al. Site-specific chemical modification of human serum albumin with polyethylene glycol prolongs half-life and improves intravascular retention in mice. Biol. Pharm. Bull. 35, 280\u2013288 (2012).","journal-title":"Biol. Pharm. Bull."},{"key":"BFncomms8939_CR42","doi-asserted-by":"publisher","first-page":"229ra43","DOI":"10.1126\/scitranslmed.3007965","volume":"6","author":"LM Zasadil","year":"2014","unstructured":"Zasadil, L. M. et al. Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci. Transl. Med. 6, 229ra43 (2014).","journal-title":"Sci. Transl. Med."},{"key":"BFncomms8939_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jconrel.2006.06.026","volume":"116","author":"W Liu","year":"2006","unstructured":"Liu, W. et al. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J. Control Release 116, 170\u2013178 (2006).","journal-title":"J. Control Release"},{"key":"BFncomms8939_CR44","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1002\/art.22952","volume":"56","author":"MF Shamji","year":"2007","unstructured":"Shamji, M. F. et al. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic. Arthritis Rheum. 56, 3650\u20133661 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFncomms8939_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2217\/17435889.2.5.681","volume":"2","author":"X Huang","year":"2007","unstructured":"Huang, X., Jain, P. K., El-Sayed, I. H. & El-Sayed, M. A. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2, 681\u2013693 (2007).","journal-title":"Nanomedicine (Lond)"},{"key":"BFncomms8939_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd988","volume":"2","author":"CR Martin","year":"2003","unstructured":"Martin, C. R. & Kohli, P. The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov. 2, 29\u201337 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms8939_CR47","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrc1958","volume":"6","author":"R Duncan","year":"2006","unstructured":"Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 6, 688\u2013701 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms8939_CR48","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/jmri.10181","volume":"16","author":"RJ Gillies","year":"2002","unstructured":"Gillies, R. J., Raghunand, N., Karczmar, G. S. & Bhujwalla, Z. M. MRI of the tumor microenvironment. J. Magn. Reson. Imaging 16, 430\u2013450 (2002).","journal-title":"J. Magn. Reson. Imaging"},{"key":"BFncomms8939_CR49","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/BF00130362","volume":"17","author":"C Guda","year":"1995","unstructured":"Guda, C. et al. Hyperexpression of an environmentally friendly synthetic polymer gene. Biotechnol. Lett. 17, 745\u2013750 (1995).","journal-title":"Biotechnol. Lett."},{"key":"BFncomms8939_CR50","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1021\/mp100119f","volume":"7","author":"T Etrych","year":"2010","unstructured":"Etrych, T., S\u00edrov\u00e1, M., Starovoytova, L., Rihova, B. & Ulbrich, K. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Mol. Pharm. 7, 1015\u20131026 (2010).","journal-title":"Mol. Pharm."},{"key":"BFncomms8939_CR51","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/la00092a038","volume":"6","author":"CL Zhao","year":"1990","unstructured":"Zhao, C. L., Winnik, M. A., Riess, G. & Croucher, M. D. Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers. Langmuir 6, 514\u2013516 (1990).","journal-title":"Langmuir"},{"key":"BFncomms8939_CR52","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1371\/journal.pmed.0030047","volume":"3","author":"JT Chi","year":"2006","unstructured":"Chi, J. T. et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 3, e47 (2006).","journal-title":"PLoS Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms8939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms8939","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms8939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:08:56Z","timestamp":1672898936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms8939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,24]]}},"alternative-id":["BFncomms8939"],"URL":"https:\/\/doi.org\/10.1038\/ncomms8939","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,4]]},"assertion":[{"value":"13 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C. has a financial interest in a start-up company, PhaseBio Pharmaceuticals that has licensed the technology reported herein from the Duke University. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7939"}}